Bank of New York Mellon’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-347,801
| Closed | -$6.91M | – | 4529 |
|
|
2023
Q1 | $6.91M | Sell |
347,801
-4,482
| -1% | -$77.4K | ﹤0.01% | 2123 |
|
|
2022
Q4 | $4.8M | Sell |
352,283
-8,489
| -2% | -$118K | ﹤0.01% | 2366 |
|
|
2022
Q3 | $5M | Buy |
360,772
+1,595
| +0.4% | +$23.7K | ﹤0.01% | 2292 |
|
|
2022
Q2 | $5.16M | Sell |
359,177
-11,025
| -3% | -$191K | ﹤0.01% | 2275 |
|
|
2022
Q1 | $8.37M | Buy |
370,202
+17,429
| +5% | +$338K | ﹤0.01% | 2161 |
|
|
2021
Q4 | $6.63M | Sell |
352,773
-176
| -0% | -$4.7K | ﹤0.01% | 2318 |
|
|
2021
Q3 | $11.6M | Buy |
352,949
+3,521
| +1% | +$131K | ﹤0.01% | 2040 |
|
|
2021
Q2 | $14.9M | Sell |
349,428
-36,851
| -10% | -$1.44M | ﹤0.01% | 1904 |
|
|
2021
Q1 | $14.8M | Sell |
386,279
-6,851
| -2% | -$292K | ﹤0.01% | 1878 |
|
|
2020
Q4 | $17.2M | Sell |
393,130
-2,347
| -0.6% | -$88.3K | ﹤0.01% | 1718 |
|
|
2020
Q3 | $15.6M | Buy |
395,477
+21,987
| +6% | +$710K | ﹤0.01% | 1612 |
|
|
2020
Q2 | $11.8M | Buy |
373,490
+2,135
| +0.6% | +$79.7K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $13.1M | Sell |
371,355
-14,360
| -4% | -$605K | ﹤0.01% | 1542 |
|
|
2019
Q4 | $18.7M | Sell |
385,715
-25,027
| -6% | -$1.14M | ﹤0.01% | 1611 |
|
|
2019
Q3 | $19.5M | Buy |
410,742
+13,949
| +4% | +$655K | 0.01% | 1538 |
|
|
2019
Q2 | $17M | Sell |
396,793
-104,515
| -21% | -$4.06M | ﹤0.01% | 1654 |
|
|
2019
Q1 | $19.4M | Buy |
501,308
+349,147
| +229% | +$11.8M | 0.01% | 1557 |
|
|
2018
Q4 | $4.33M | Buy |
152,161
+3,888
| +3% | +$124K | ﹤0.01% | 2385 |
|
|
2018
Q3 | $5.8M | Sell |
148,273
-2,930
| -2% | -$108K | ﹤0.01% | 2336 |
|
|
2018
Q2 | $4.89M | Sell |
151,203
-5,287
| -3% | -$145K | ﹤0.01% | 2399 |
|
|
2018
Q1 | $3.43M | Sell |
156,490
-37,527
| -19% | -$902K | ﹤0.01% | 2531 |
|
|
2017
Q4 | $4.6M | Buy |
194,017
+1,181
| +0.6% | +$29.8K | ﹤0.01% | 2397 |
|
|
2017
Q3 | $5.43M | Sell |
192,836
-16,193
| -8% | -$493K | ﹤0.01% | 2297 |
|
|
2017
Q2 | $6.74M | Buy |
209,029
+27,539
| +15% | +$839K | ﹤0.01% | 2175 |
|
|
2017
Q1 | $5.13M | Buy |
181,490
+4,495
| +3% | +$119K | ﹤0.01% | 2315 |
|
|
2016
Q4 | $4.29M | Sell |
176,995
-895
| -0.5% | -$22K | ﹤0.01% | 2403 |
|
|
2016
Q3 | $4.22M | Buy |
177,890
+35,577
| +25% | +$779K | ﹤0.01% | 2323 |
|
|
2016
Q2 | $2.62M | Buy |
142,313
+6,437
| +5% | +$101K | ﹤0.01% | 2561 |
|
|
2016
Q1 | $1.41M | Sell |
135,876
-13,121
| -9% | -$133K | ﹤0.01% | 2855 |
|
|
2015
Q4 | $2.25M | Buy |
148,997
+8,434
| +6% | +$125K | ﹤0.01% | 2644 |
|
|
2015
Q3 | $2.23M | Sell |
140,563
-18,138
| -11% | -$457K | ﹤0.01% | 2675 |
|
|
2015
Q2 | $4.2M | Sell |
158,701
-11,559
| -7% | -$373K | ﹤0.01% | 2463 |
|
|
2015
Q1 | $6.65M | Buy |
170,260
+23,380
| +16% | +$805K | ﹤0.01% | 2159 |
|
|
2014
Q4 | $4.42M | Buy |
146,880
+5,181
| +4% | +$148K | ﹤0.01% | 2374 |
|
|
2014
Q3 | $3.35M | Sell |
141,699
-13,710
| -9% | -$390K | ﹤0.01% | 2546 |
|
|
2014
Q2 | $4.84M | Sell |
155,409
-1,935
| -1% | -$55.8K | ﹤0.01% | 2337 |
|
|
2014
Q1 | $5M | Buy |
157,344
+15,580
| +11% | +$515K | ﹤0.01% | 2311 |
|
|
2013
Q4 | $4.86M | Buy |
141,764
+11,830
| +9% | +$344K | ﹤0.01% | 2310 |
|
|
2013
Q3 | $2.6M | Buy |
129,934
+17,569
| +16% | +$366K | ﹤0.01% | 2675 |
|
|
2013
Q2 | $2.38M | Buy |
+112,365
| New | +$2.18M | ﹤0.01% | 2685 |
|
Other funds holding CSII
Bank of New York Mellon's CSII Position: Q2 2023 in Review
Bank of New York Mellon sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 347,801 shares — an estimated $6.91M sold.
Bank of New York Mellon first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $19.5M in Q3 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Bank of New York Mellon reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Bank of New York Mellon sold 347,801 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $6.91M.
- Bank of New York Mellon first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
- Bank of New York Mellon's Cardiovascular Systems, Inc. position peaked at $19.5M in Q3 2019.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.